My watch list
my.bionity.com  
Login  

360 Current news from israel

rss
matching the following criteria

Recipharm makes strategic investment in Synthonics

16-Apr-2015

Recipharm announced that it has made an equity investment in Synthonics Inc and purchased $2.0 million of preferred stock in the company.A further $2.0 million of preferred stock will be purchased upon Synthonics’ achievement of certain milestones, which could be expected during 2016. In ...

more

Pharmalink announces positive results in Phase 2b trial of Nefecon

16-Apr-2015

Pharmalink AB announced that the NEFIGAN Trial of Nefecon® for the treatment of primary IgA nephropathy has fully met its primary efficacy endpoint at a planned interim analysis and been stopped early with respect to statistical analysis of the endpoint. The NEFIGAN Trial is a Phase 2b randomized ...

more

Infant Bacterial Therapeutics gets Orphan Drug Designation in Europe

25-Feb-2015

Infant Bacterial Therapeutics (IBT), subsidiary of BioGaia, is in the early stages of developing a drug to prevent necrotizing enterocolitis (NEC) which is a rare and fatal disease that affects premature infants. IBT has now obtained the Orphan Drug Designation for the prevention of NEC in ...

more

Amyloid formation may link Alzheimer disease and type 2 diabetes

18-Feb-2015

The pathological process amyloidosis, in which misfolded proteins (amyloids) form insoluble fibril deposits, occurs in many diseases, including Alzheimer disease (AD) and type 2 diabetes mellitus (T2D). However, little is known about whether different forms of amyloid proteins interact or how ...

more

Xiapex approved by the EU Commission for the treatment of Peyronie's disease

03-Feb-2015

Swedish Orphan Biovitrum AB (publ) (Sobi) announced that the EU Commission has approved Xiapex® (collagenase clostridium histolyticum) for the treatment of adult men with Peyronie's disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy. Peyronie's ...

more

Danaher controls more than 98% of Nobel Biocare and started squeeze out procedure

Nobel Biocare applied for delisting

21-Jan-2015

Nobel Biocare Holding AG has been informed that Danaher Corporation filed a petition with the Commercial Court of the Canton of Zurich for the annulation (Kraftloserklärung) of the remaining publicly held registered shares of Nobel Biocare against payment of the offer price that had been offered ...

more

Nobel Biocare appoints new Chief Financial Officer

08-Jan-2015

Nobel Biocare announced that effective February 1, 2015, Mr. Tullio Di Dio will be appointed Chief Financial Officer of Nobel Biocare succeeding Mr. Oliver Walker as he has decided to leave the company to pursue his career interests outside Nobel Biocare. Mr. Di Dio joins Nobel Biocare with 23 ...

more

New leaders elected for the Royal Swedish Academy of Sciences

23-Dec-2014

At the general meeting, the Royal Swedish Academy of Sciences elected its two foremost representatives, who will take over the roles of the current President and Permanent Secretary on 1 July 2015. Christina Moberg to be the new President The new President, the foremost representative of the ...

more

Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease

23-Dec-2014

Swedish Orphan Biovitrum AB and partner Auxilium Pharmaceuticals, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the use of Xiapex® (collagenase clostridium histolyticum) for the treatment of ...

more

Recipharm acquires Flamel Technologies facility and extend development services in France

01-Dec-2014

Recipharm AB and Flamel Technologies SA announced that they have entered into a long term collaboration and signed an agreement whereby Recipharm will purchase Flamel’s development and manufacturing facility located in Pessac, France. Recipharm will significantly expand its pharmaceutical ...

more

Page 1 From 36
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE
?>